Alterola Biotech, Inc.
Alterola Biotech, Inc. (ABTI) Stock Competitors & Peer Comparison
See (ABTI) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
ABTI | $0.00 | +0.00% | 291.9K | -0.02 | -$0.01 | N/A |
MKGAF | $124.50 | -2.83% | 55.5B | 17.25 | $7.40 | +2.08% |
MKKGY | $24.69 | -1.52% | 54.2B | 16.63 | $1.50 | +2.03% |
TKPHF | $27.50 | +0.00% | 43B | 47.41 | $0.58 | +4.84% |
HLNCF | $4.62 | -0.86% | 41.5B | 21.98 | $0.21 | +1.87% |
IPSEY | $30.05 | -6.73% | 40.7B | 19.71 | $1.56 | +0.81% |
SDZNY | $55.91 | -1.52% | 24.1B | -2797.00 | -$0.02 | +1.21% |
ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
TEVJF | $14.00 | +0.00% | 16.1B | -93.33 | -$0.15 | N/A |
SGIOY | $8.87 | +1.49% | 15.1B | 13.04 | $0.68 | +1.80% |
Stock Comparison
ABTI vs MKGAF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, MKGAF has a market cap of 55.5B. Regarding current trading prices, ABTI is priced at $0.00, while MKGAF trades at $124.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas MKGAF's P/E ratio is 17.25. In terms of profitability, ABTI's ROE is -0.15%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, ABTI is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check MKGAF's competition here
ABTI vs MKKGY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, MKKGY has a market cap of 54.2B. Regarding current trading prices, ABTI is priced at $0.00, while MKKGY trades at $24.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas MKKGY's P/E ratio is 16.63. In terms of profitability, ABTI's ROE is -0.15%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, ABTI is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check MKKGY's competition here
ABTI vs TKPHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, TKPHF has a market cap of 43B. Regarding current trading prices, ABTI is priced at $0.00, while TKPHF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas TKPHF's P/E ratio is 47.41. In terms of profitability, ABTI's ROE is -0.15%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, ABTI is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check TKPHF's competition here
ABTI vs HLNCF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HLNCF has a market cap of 41.5B. Regarding current trading prices, ABTI is priced at $0.00, while HLNCF trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HLNCF's P/E ratio is 21.98. In terms of profitability, ABTI's ROE is -0.15%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, ABTI is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HLNCF's competition here
ABTI vs IPSEY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, IPSEY has a market cap of 40.7B. Regarding current trading prices, ABTI is priced at $0.00, while IPSEY trades at $30.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas IPSEY's P/E ratio is 19.71. In terms of profitability, ABTI's ROE is -0.15%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, ABTI is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check IPSEY's competition here
ABTI vs SDZNY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SDZNY has a market cap of 24.1B. Regarding current trading prices, ABTI is priced at $0.00, while SDZNY trades at $55.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SDZNY's P/E ratio is -2797.00. In terms of profitability, ABTI's ROE is -0.15%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, ABTI is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SDZNY's competition here
ABTI vs ESALY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, ABTI is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas ESALY's P/E ratio is 20.54. In terms of profitability, ABTI's ROE is -0.15%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, ABTI is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check ESALY's competition here
ABTI vs TEVJF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, TEVJF has a market cap of 16.1B. Regarding current trading prices, ABTI is priced at $0.00, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas TEVJF's P/E ratio is -93.33. In terms of profitability, ABTI's ROE is -0.15%, compared to TEVJF's ROE of -0.03%. Regarding short-term risk, ABTI is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check TEVJF's competition here
ABTI vs SGIOY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SGIOY has a market cap of 15.1B. Regarding current trading prices, ABTI is priced at $0.00, while SGIOY trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SGIOY's P/E ratio is 13.04. In terms of profitability, ABTI's ROE is -0.15%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, ABTI is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SGIOY's competition here
ABTI vs SGIOF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SGIOF has a market cap of 14.3B. Regarding current trading prices, ABTI is priced at $0.00, while SGIOF trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SGIOF's P/E ratio is 12.35. In terms of profitability, ABTI's ROE is -0.15%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, ABTI is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SGIOF's competition here
ABTI vs BIOVF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, ABTI is priced at $0.00, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas BIOVF's P/E ratio is 22.74. In terms of profitability, ABTI's ROE is -0.15%, compared to BIOVF's ROE of +0.11%. Regarding short-term risk, ABTI is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check BIOVF's competition here
ABTI vs IPSEF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, ABTI is priced at $0.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas IPSEF's P/E ratio is 18.19. In terms of profitability, ABTI's ROE is -0.15%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, ABTI is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check IPSEF's competition here
ABTI vs SFOSF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SFOSF has a market cap of 9B. Regarding current trading prices, ABTI is priced at $0.00, while SFOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SFOSF's P/E ratio is 15.33. In terms of profitability, ABTI's ROE is -0.15%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, ABTI is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SFOSF's competition here
ABTI vs ESALF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, ESALF has a market cap of 8.3B. Regarding current trading prices, ABTI is priced at $0.00, while ESALF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas ESALF's P/E ratio is 26.35. In terms of profitability, ABTI's ROE is -0.15%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, ABTI is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check ESALF's competition here
ABTI vs ESAIY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, ESAIY has a market cap of 8.1B. Regarding current trading prices, ABTI is priced at $0.00, while ESAIY trades at $7.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas ESAIY's P/E ratio is 25.54. In terms of profitability, ABTI's ROE is -0.15%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, ABTI is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check ESAIY's competition here
ABTI vs GZPHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, GZPHF has a market cap of 6B. Regarding current trading prices, ABTI is priced at $0.00, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas GZPHF's P/E ratio is 10.22. In terms of profitability, ABTI's ROE is -0.15%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, ABTI is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check GZPHF's competition here
ABTI vs HKMPF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HKMPF has a market cap of 5.8B. Regarding current trading prices, ABTI is priced at $0.00, while HKMPF trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HKMPF's P/E ratio is 16.38. In terms of profitability, ABTI's ROE is -0.15%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, ABTI is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HKMPF's competition here
ABTI vs HKMPY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HKMPY has a market cap of 5.7B. Regarding current trading prices, ABTI is priced at $0.00, while HKMPY trades at $51.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HKMPY's P/E ratio is 15.99. In terms of profitability, ABTI's ROE is -0.15%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, ABTI is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HKMPY's competition here
ABTI vs SGFEF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, ABTI is priced at $0.00, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SGFEF's P/E ratio is 24.91. In terms of profitability, ABTI's ROE is -0.15%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, ABTI is more volatile compared to SGFEF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SGFEF's competition here
ABTI vs WIBFF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, ABTI is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, ABTI's ROE is -0.15%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, ABTI is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ABTI.Check WIBFF's competition here
ABTI vs HLUBF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HLUBF has a market cap of 4.5B. Regarding current trading prices, ABTI is priced at $0.00, while HLUBF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HLUBF's P/E ratio is 9.13. In terms of profitability, ABTI's ROE is -0.15%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, ABTI is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HLUBF's competition here
ABTI vs HLBBF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HLBBF has a market cap of 4.1B. Regarding current trading prices, ABTI is priced at $0.00, while HLBBF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HLBBF's P/E ratio is 9.90. In terms of profitability, ABTI's ROE is -0.15%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, ABTI is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HLBBF's competition here
ABTI vs SMDPY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SMDPY has a market cap of 3.7B. Regarding current trading prices, ABTI is priced at $0.00, while SMDPY trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SMDPY's P/E ratio is 23.15. In terms of profitability, ABTI's ROE is -0.15%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, ABTI is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SMDPY's competition here
ABTI vs LVZPF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, LVZPF has a market cap of 3.5B. Regarding current trading prices, ABTI is priced at $0.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, ABTI's ROE is -0.15%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, ABTI is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check LVZPF's competition here
ABTI vs ULIHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, ULIHF has a market cap of 3.5B. Regarding current trading prices, ABTI is priced at $0.00, while ULIHF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas ULIHF's P/E ratio is 8.75. In terms of profitability, ABTI's ROE is -0.15%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, ABTI is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check ULIHF's competition here
ABTI vs CHSYF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, ABTI is priced at $0.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CHSYF's P/E ratio is 15.00. In terms of profitability, ABTI's ROE is -0.15%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, ABTI is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CHSYF's competition here
ABTI vs APNHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, ABTI is priced at $0.00, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas APNHF's P/E ratio is 13.18. In terms of profitability, ABTI's ROE is -0.15%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, ABTI is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check APNHF's competition here
ABTI vs INVVY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, ABTI is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas INVVY's P/E ratio is -62.42. In terms of profitability, ABTI's ROE is -0.15%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, ABTI is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check INVVY's competition here
ABTI vs IZQVF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, ABTI is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, ABTI's ROE is -0.15%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, ABTI is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check IZQVF's competition here
ABTI vs DNPUF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, ABTI is priced at $0.00, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas DNPUF's P/E ratio is 18.10. In terms of profitability, ABTI's ROE is -0.15%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, ABTI is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check DNPUF's competition here
ABTI vs LBTSF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, ABTI is priced at $0.00, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas LBTSF's P/E ratio is 121.45. In terms of profitability, ABTI's ROE is -0.15%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, ABTI is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check LBTSF's competition here
ABTI vs APNHY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, APNHY has a market cap of 2.8B. Regarding current trading prices, ABTI is priced at $0.00, while APNHY trades at $6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas APNHY's P/E ratio is 11.36. In terms of profitability, ABTI's ROE is -0.15%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, ABTI is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check APNHY's competition here
ABTI vs HMDCF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, ABTI is priced at $0.00, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, ABTI's ROE is -0.15%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, ABTI is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HMDCF's competition here
ABTI vs HYPMY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HYPMY has a market cap of 2.8B. Regarding current trading prices, ABTI is priced at $0.00, while HYPMY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HYPMY's P/E ratio is 19.13. In terms of profitability, ABTI's ROE is -0.15%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, ABTI is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HYPMY's competition here
ABTI vs THCBF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, ABTI is priced at $0.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas THCBF's P/E ratio is -0.10. In terms of profitability, ABTI's ROE is -0.15%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, ABTI is more volatile compared to THCBF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check THCBF's competition here
ABTI vs DMPHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, ABTI is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, ABTI's ROE is -0.15%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, ABTI is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check DMPHF's competition here
ABTI vs HTSUF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, ABTI is priced at $0.00, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HTSUF's P/E ratio is 15.99. In terms of profitability, ABTI's ROE is -0.15%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, ABTI is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HTSUF's competition here
ABTI vs LJUIF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, ABTI is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, ABTI's ROE is -0.15%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, ABTI is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check LJUIF's competition here
ABTI vs CASBF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CASBF has a market cap of 2B. Regarding current trading prices, ABTI is priced at $0.00, while CASBF trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CASBF's P/E ratio is -30.48. In terms of profitability, ABTI's ROE is -0.15%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, ABTI is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CASBF's competition here
ABTI vs ARSUF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, ABTI is priced at $0.00, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, ABTI's ROE is -0.15%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, ABTI is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check ARSUF's competition here
ABTI vs TSMRF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, ABTI is priced at $0.00, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas TSMRF's P/E ratio is 8.19. In terms of profitability, ABTI's ROE is -0.15%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, ABTI is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check TSMRF's competition here
ABTI vs NPNKF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, ABTI is priced at $0.00, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas NPNKF's P/E ratio is 7.80. In terms of profitability, ABTI's ROE is -0.15%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, ABTI is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check NPNKF's competition here
ABTI vs YIHCF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, ABTI is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, ABTI's ROE is -0.15%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, ABTI is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check YIHCF's competition here
ABTI vs MITPF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, ABTI is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas MITPF's P/E ratio is -10.81. In terms of profitability, ABTI's ROE is -0.15%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, ABTI is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check MITPF's competition here
ABTI vs GTBIF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, ABTI is priced at $0.00, while GTBIF trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas GTBIF's P/E ratio is 31.74. In terms of profitability, ABTI's ROE is -0.15%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, ABTI is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check GTBIF's competition here
ABTI vs KARBF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, ABTI is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas KARBF's P/E ratio is 262.50. In terms of profitability, ABTI's ROE is -0.15%, compared to KARBF's ROE of N/A. Regarding short-term risk, ABTI is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check KARBF's competition here
ABTI vs EVOTF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, ABTI is priced at $0.00, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas EVOTF's P/E ratio is -6.26. In terms of profitability, ABTI's ROE is -0.15%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, ABTI is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check EVOTF's competition here
ABTI vs SHEZF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SHEZF has a market cap of 1.5B. Regarding current trading prices, ABTI is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, ABTI's ROE is -0.15%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, ABTI is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SHEZF's competition here
ABTI vs NPPNY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, ABTI is priced at $0.00, while NPPNY trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas NPPNY's P/E ratio is 6.52. In terms of profitability, ABTI's ROE is -0.15%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, ABTI is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check NPPNY's competition here
ABTI vs CHIZF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, ABTI is priced at $0.00, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, ABTI's ROE is -0.15%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, ABTI is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CHIZF's competition here
ABTI vs CURLF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CURLF has a market cap of 1.3B. Regarding current trading prices, ABTI is priced at $0.00, while CURLF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CURLF's P/E ratio is -5.09. In terms of profitability, ABTI's ROE is -0.15%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, ABTI is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CURLF's competition here
ABTI vs KSPHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, ABTI is priced at $0.00, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas KSPHF's P/E ratio is 16.28. In terms of profitability, ABTI's ROE is -0.15%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, ABTI is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check KSPHF's competition here
ABTI vs GNMLF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, ABTI is priced at $0.00, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, ABTI's ROE is -0.15%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, ABTI is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check GNMLF's competition here
ABTI vs SWGHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, ABTI is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, ABTI's ROE is -0.15%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, ABTI is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SWGHF's competition here
ABTI vs KKPCF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, ABTI is priced at $0.00, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, ABTI's ROE is -0.15%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, ABTI is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check KKPCF's competition here
ABTI vs TCNNF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, TCNNF has a market cap of 1B. Regarding current trading prices, ABTI is priced at $0.00, while TCNNF trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas TCNNF's P/E ratio is -6.67. In terms of profitability, ABTI's ROE is -0.15%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, ABTI is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check TCNNF's competition here
ABTI vs BIOGY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, BIOGY has a market cap of 992.4M. Regarding current trading prices, ABTI is priced at $0.00, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas BIOGY's P/E ratio is 33.62. In terms of profitability, ABTI's ROE is -0.15%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, ABTI is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check BIOGY's competition here
ABTI vs NIKA Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, NIKA has a market cap of 972.9M. Regarding current trading prices, ABTI is priced at $0.00, while NIKA trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas NIKA's P/E ratio is N/A. In terms of profitability, ABTI's ROE is -0.15%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, ABTI is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check NIKA's competition here
ABTI vs SHPHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, ABTI is priced at $0.00, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, ABTI's ROE is -0.15%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, ABTI is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SHPHF's competition here
ABTI vs LVTTF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, LVTTF has a market cap of 890.7M. Regarding current trading prices, ABTI is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, ABTI's ROE is -0.15%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, ABTI is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ABTI.Check LVTTF's competition here
ABTI vs EVRRF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, EVRRF has a market cap of 886.9M. Regarding current trading prices, ABTI is priced at $0.00, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, ABTI's ROE is -0.15%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, ABTI is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check EVRRF's competition here
ABTI vs NRXCF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, NRXCF has a market cap of 841.5M. Regarding current trading prices, ABTI is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, ABTI's ROE is -0.15%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, ABTI is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check NRXCF's competition here
ABTI vs TWAPF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, ABTI is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, ABTI's ROE is -0.15%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, ABTI is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check TWAPF's competition here
ABTI vs SWDCF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, SWDCF has a market cap of 773.6M. Regarding current trading prices, ABTI is priced at $0.00, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas SWDCF's P/E ratio is 121.00. In terms of profitability, ABTI's ROE is -0.15%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, ABTI is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check SWDCF's competition here
ABTI vs CSWYF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, ABTI is priced at $0.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, ABTI's ROE is -0.15%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, ABTI is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CSWYF's competition here
ABTI vs TRXPF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, ABTI is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, ABTI's ROE is -0.15%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, ABTI is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check TRXPF's competition here
ABTI vs TRSSF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, ABTI is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, ABTI's ROE is -0.15%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, ABTI is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check TRSSF's competition here
ABTI vs ELTP Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, ELTP has a market cap of 576.8M. Regarding current trading prices, ABTI is priced at $0.00, while ELTP trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas ELTP's P/E ratio is -26.93. In terms of profitability, ABTI's ROE is -0.15%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, ABTI is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check ELTP's competition here
ABTI vs PKBFF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, PKBFF has a market cap of 544.1M. Regarding current trading prices, ABTI is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas PKBFF's P/E ratio is N/A. In terms of profitability, ABTI's ROE is -0.15%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, ABTI is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check PKBFF's competition here
ABTI vs AIHLF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, AIHLF has a market cap of 543.1M. Regarding current trading prices, ABTI is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, ABTI's ROE is -0.15%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, ABTI is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check AIHLF's competition here
ABTI vs CCHWF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, ABTI is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, ABTI's ROE is -0.15%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, ABTI is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CCHWF's competition here
ABTI vs PEXXF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, ABTI is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, ABTI's ROE is -0.15%, compared to PEXXF's ROE of N/A. Regarding short-term risk, ABTI is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check PEXXF's competition here
ABTI vs KHTRF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, KHTRF has a market cap of 453.4M. Regarding current trading prices, ABTI is priced at $0.00, while KHTRF trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas KHTRF's P/E ratio is 65.00. In terms of profitability, ABTI's ROE is -0.15%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, ABTI is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check KHTRF's competition here
ABTI vs GLASF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, GLASF has a market cap of 430.6M. Regarding current trading prices, ABTI is priced at $0.00, while GLASF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas GLASF's P/E ratio is -67.78. In terms of profitability, ABTI's ROE is -0.15%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, ABTI is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check GLASF's competition here
ABTI vs BOIRF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, BOIRF has a market cap of 416.7M. Regarding current trading prices, ABTI is priced at $0.00, while BOIRF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas BOIRF's P/E ratio is 16.90. In terms of profitability, ABTI's ROE is -0.15%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, ABTI is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check BOIRF's competition here
ABTI vs AGYTF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, ABTI is priced at $0.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, ABTI's ROE is -0.15%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, ABTI is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check AGYTF's competition here
ABTI vs HUMDF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, ABTI is priced at $0.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, ABTI's ROE is -0.15%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, ABTI is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HUMDF's competition here
ABTI vs FFNTF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, FFNTF has a market cap of 331.9M. Regarding current trading prices, ABTI is priced at $0.00, while FFNTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas FFNTF's P/E ratio is N/A. In terms of profitability, ABTI's ROE is -0.15%, compared to FFNTF's ROE of +0.75%. Regarding short-term risk, ABTI is more volatile compared to FFNTF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check FFNTF's competition here
ABTI vs VRNOF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, VRNOF has a market cap of 301.4M. Regarding current trading prices, ABTI is priced at $0.00, while VRNOF trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas VRNOF's P/E ratio is -0.84. In terms of profitability, ABTI's ROE is -0.15%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, ABTI is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check VRNOF's competition here
ABTI vs CPHRF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CPHRF has a market cap of 239.6M. Regarding current trading prices, ABTI is priced at $0.00, while CPHRF trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CPHRF's P/E ratio is 25.97. In terms of profitability, ABTI's ROE is -0.15%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, ABTI is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CPHRF's competition here
ABTI vs CRLBF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CRLBF has a market cap of 232.1M. Regarding current trading prices, ABTI is priced at $0.00, while CRLBF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CRLBF's P/E ratio is -2.86. In terms of profitability, ABTI's ROE is -0.15%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, ABTI is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CRLBF's competition here
ABTI vs BHCCF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, ABTI is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, ABTI's ROE is -0.15%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, ABTI is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check BHCCF's competition here
ABTI vs PLNHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, ABTI is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, ABTI's ROE is -0.15%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, ABTI is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check PLNHF's competition here
ABTI vs PHCUF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, PHCUF has a market cap of 159.9M. Regarding current trading prices, ABTI is priced at $0.00, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas PHCUF's P/E ratio is -300.00. In terms of profitability, ABTI's ROE is -0.15%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, ABTI is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check PHCUF's competition here
ABTI vs CBWTF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CBWTF has a market cap of 146.1M. Regarding current trading prices, ABTI is priced at $0.00, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CBWTF's P/E ratio is 5.47. In terms of profitability, ABTI's ROE is -0.15%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, ABTI is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CBWTF's competition here
ABTI vs COPHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, ABTI is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas COPHF's P/E ratio is -0.02. In terms of profitability, ABTI's ROE is -0.15%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, ABTI is more volatile compared to COPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check COPHF's competition here
ABTI vs LOVFF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, LOVFF has a market cap of 127.1M. Regarding current trading prices, ABTI is priced at $0.00, while LOVFF trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas LOVFF's P/E ratio is 13.90. In terms of profitability, ABTI's ROE is -0.15%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, ABTI is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check LOVFF's competition here
ABTI vs STMH Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, STMH has a market cap of 125.5M. Regarding current trading prices, ABTI is priced at $0.00, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas STMH's P/E ratio is N/A. In terms of profitability, ABTI's ROE is -0.15%, compared to STMH's ROE of -2.75%. Regarding short-term risk, ABTI is more volatile compared to STMH. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check STMH's competition here
ABTI vs JUSHF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, JUSHF has a market cap of 124.5M. Regarding current trading prices, ABTI is priced at $0.00, while JUSHF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas JUSHF's P/E ratio is -2.53. In terms of profitability, ABTI's ROE is -0.15%, compared to JUSHF's ROE of +1.06%. Regarding short-term risk, ABTI is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check JUSHF's competition here
ABTI vs NWPN Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, ABTI is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas NWPN's P/E ratio is -0.04. In terms of profitability, ABTI's ROE is -0.15%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, ABTI is more volatile compared to NWPN. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check NWPN's competition here
ABTI vs HLTRF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, HLTRF has a market cap of 116.2M. Regarding current trading prices, ABTI is priced at $0.00, while HLTRF trades at $3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas HLTRF's P/E ratio is -6.47. In terms of profitability, ABTI's ROE is -0.15%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, ABTI is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check HLTRF's competition here
ABTI vs LPCUF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, ABTI is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, ABTI's ROE is -0.15%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, ABTI is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check LPCUF's competition here
ABTI vs CNVCF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, ABTI is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, ABTI's ROE is -0.15%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, ABTI is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check CNVCF's competition here
ABTI vs GRUSF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, GRUSF has a market cap of 96.7M. Regarding current trading prices, ABTI is priced at $0.00, while GRUSF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas GRUSF's P/E ratio is -13.00. In terms of profitability, ABTI's ROE is -0.15%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, ABTI is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check GRUSF's competition here
ABTI vs BIOYF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, BIOYF has a market cap of 94.8M. Regarding current trading prices, ABTI is priced at $0.00, while BIOYF trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas BIOYF's P/E ratio is 17.21. In terms of profitability, ABTI's ROE is -0.15%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, ABTI is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check BIOYF's competition here
ABTI vs AAWH Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, AAWH has a market cap of 94.3M. Regarding current trading prices, ABTI is priced at $0.00, while AAWH trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas AAWH's P/E ratio is -1.15. In terms of profitability, ABTI's ROE is -0.15%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, ABTI is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check AAWH's competition here
ABTI vs LRDSF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, LRDSF has a market cap of 83.8M. Regarding current trading prices, ABTI is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, ABTI's ROE is -0.15%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, ABTI is more volatile compared to LRDSF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check LRDSF's competition here
ABTI vs ABSCF Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, ABSCF has a market cap of 77.4M. Regarding current trading prices, ABTI is priced at $0.00, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, ABTI's ROE is -0.15%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, ABTI is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check ABSCF's competition here
ABTI vs EOFBY Comparison August 2025
ABTI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ABTI stands at 291.9K. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, ABTI is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ABTI currently has a P/E ratio of -0.02, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, ABTI's ROE is -0.15%, compared to EOFBY's ROE of N/A. Regarding short-term risk, ABTI is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for ABTI.Check EOFBY's competition here